| dc.contributor | Wiley | es_CL |
| dc.contributor.author | Sung, H [Universidad de Chile] | es_CL |
| dc.contributor.author | Sepúlveda, D. [Universidad de Chile] | es_CL |
| dc.contributor.author | González, M. J. [Universidad de Chile] | es_CL |
| dc.contributor.author | Molina, C. [Chile. Universidad Mayor] | es_CL |
| dc.date.accessioned | 2018-09-07T14:11:43Z | |
| dc.date.available | 2018-09-07T14:11:43Z | |
| dc.date.issued | 2014 | es_CL |
| dc.identifier.citation | González, S., Sung, H., Sepúlveda, D., Gonzalez, M. J., & Molina, C. (2014). Oral manifestations and their treatment in S jögren′ s syndrome. Oral diseases, 20(2), 153-161. | es_CL |
| dc.identifier.issn | ISSN 1354-523X | es_CL |
| dc.identifier.issn | ESSN 1601-0825 | es_CL |
| dc.identifier.uri | https://onlinelibrary.wiley.com/doi/epdf/10.1111/odi.12105 | es_CL |
| dc.identifier.uri | https://doi.org/10.1111/odi.12105 | es_CL |
| dc.identifier.uri | http://repositorio.umayor.cl/xmlui/handle/sibum/2749 | |
| dc.description.abstract | Sjögren's syndrome (SS) is a complex, chronic, systemic, autoimmune disease that mainly affects the exocrine glands, especially the salivary and lacrimal glands, leading to dryness of the oral and ocular mucosae. Several factors have been studied that could explain the glandular hypofunction primarily related to water transport. Recent reports have shown alterations in secretory route and trafficking in labial salivary glands, explaining alterations in the saliva quality. The decrease in salivary flow and qualitative alterations in saliva could explain many of the oral manifestations. The exocrine manifestations and systemic involvement significantly impact the patient's perception of health‐related quality of life. For this reason and given its systemic nature, the treatment of these patients should be multidisciplinary. This review addresses some particular oral health aspects of SS patients and focuses on relevant topics concerning the treatment and prevention of common oral disorders associated with this disease. | es_CL |
| dc.description.sponsorship | Este trabajo fue financiado por: Fondecyt-Chile 1120062, PhD-fellowship BEP (DS) | es_CL |
| dc.format.extent | REVISIÓN | es_CL |
| dc.language.iso | en | es_CL |
| dc.publisher | CIENCIAS | es_CL |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | es_CL |
| dc.subject | ODONTOLOGÍA | es_CL |
| dc.title | Oral manifestations and their treatment in Sjogren's syndrome | es_CL |
| dc.type | Artículo o Paper | es_CL |
| umayor.indizador | COT | es_CL |
| umayor.politicas.sherpa/romeo | Licencia color: AMARILLO (Puede archivar el pre-print (ie la versión previa a la revisión por pares))--Pre-print del autor: el autor puede archivar la versión pre-print (ie la versión previa a la revisión por pares). Postprint: el autor puede archivar la versión post-print (ie la versión final posterior a la revisión por pares) siempre que se cumplan las restricciones que se indican más abajo. Limitaciones: 12 meses de embargo, Versión de editor/PDF: cross el autor no puede archivar la versión del editor/PDF, Condiciones generales: Algunas revistas tienen políticas independientes, consultar directamente con cada revista, On author's personal website, institutional repositories, arXiv, AgEcon, PhilPapers, PubMed Central, RePEc or Social Science Research Network, Author's pre-print may not be updated with Publisher's Version/PDF, Author's pre-print must acknowledge acceptance for publication, No comercial, La versión de editor/PDF no puede utilizarse, Debe reconocerse la fuente de publicación con la cita, Must link to publisher version with set statement (see policy), If OnlineOpen is available, BBSRC, EPSRC, MRC, NERC and STFC authors, may self-archive after 12 months// Disponible en: http://www.sherpa.ac.uk/romeo/issn/1354-523X/es/ | es_CL |
| umayor.indexado | WOS | es_CL |
| umayor.indexado | SCOPUS | es_CL |
| dc.identifier.doi | 10.1111/odi.12105 | es_CL] |
| umayor.indicadores.wos-(cuartil) | Q1 | es_CL |
| umayor.indicadores.scopus-(scimago-sjr) | sin información | es_CL |